Cargando…

Oral corticosteroid dose changes and impact on peripheral blood eosinophil counts in patients with severe eosinophilic asthma: a post hoc analysis

BACKGROUND: An inverse relationship between oral corticosteroid (OCS) dose and peripheral blood eosinophil (PBE) count is widely recognized in patients with severe eosinophilic asthma; however, there are limited data available to quantify this relationship. This post hoc analysis of the SIRIUS study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Prazma, Charlene M., Bel, Elisabeth H., Price, Robert G., Bradford, Eric S., Albers, Frank C., Yancey, Steven W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6499981/ https://www.ncbi.nlm.nih.gov/pubmed/31053134 http://dx.doi.org/10.1186/s12931-019-1056-4

Ejemplares similares

Response to Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma and Atopic Phenotypes
por: Prazma, Charlene M, et al.
Publicado: (2021)

Evaluation of sputum eosinophil count as a predictor of treatment response to mepolizumab
por: Pavord, Ian D., et al.
Publicado: (2022)

Update: Mepolizumab treatment in patients with severe eosinophilic asthma and prior omalizumab use
por: Albers, Frank C., et al.
Publicado: (2019)

Treatment response with mepolizumab in severe eosinophilic asthma patients with previous omalizumab treatment
por: Magnan, A., et al.
Publicado: (2016)

Eosinophil‐derived neurotoxin and clinical outcomes with mepolizumab in severe eosinophilic asthma
por: Howarth, Peter, et al.
Publicado: (2020)

Corticosteroid tapering with benralizumab treatment for eosinophilic asthma: PONENTE Trial
por: Menzies-Gow, Andrew, et al.
Publicado: (2019)

Efficacy of add-on mepolizumab in adolescents with severe eosinophilic asthma
por: Yancey, Steven W., et al.
Publicado: (2019)

Targeting the IL-5 pathway in eosinophilic asthma: a comparison of mepolizumab to benralizumab in the reduction of peripheral eosinophil counts
por: Ghassemian, Arian, et al.
Publicado: (2021)

Bronchiectasis-COPD Overlap Syndrome: Role of Peripheral Eosinophil Count and Inhaled Corticosteroid Treatment
por: Oscullo, Grace, et al.
Publicado: (2023)

Subcutaneous mepolizumab in children aged 6 to 11 years with severe eosinophilic asthma
por: Gupta, Atul, et al.
Publicado: (2019)

Development of methodology for assessing steroid-tapering in clinical trials for biologics in asthma
por: Korn, Stephanie, et al.
Publicado: (2022)

Cumulative corticosteroid-sparing effect of anti-interleukin-5/5Ra in eosinophilic asthma
por: Kroes, Johannes A., et al.
Publicado: (2022)

Peripheral eosinophil count and eosinophil-to-lymphocyte ratio are associated with revision sinus surgery
por: Bayer, Karina, et al.
Publicado: (2022)

Health outcomes after stopping long-term mepolizumab in severe eosinophilic asthma: COMET
por: Liu, Mark C., et al.
Publicado: (2022)

Diagnostic possibility of the combination of exhaled nitric oxide and blood eosinophil count for eosinophilic asthma
por: Li, Jiang-Hua, et al.
Publicado: (2021)

Factors that affect blood eosinophil counts in a non-asthmatic population: Post hoc analysis of data from Brazil
por: Kwon, Namhee, et al.
Publicado: (2020)

Changes in Peripheral Blood Eosinophil Counts and Risk of Eosinophilic Granulomatosis with Polyangiitis Onset after Initiation of Dupilumab Administration in Adult Patients with Asthma
por: Kushima, Yoshitomo, et al.
Publicado: (2023)

Reduced Local Response to Corticosteroids in Eosinophilic Chronic Rhinosinusitis with Asthma
por: Kobayashi, Yoshiki, et al.
Publicado: (2020)

Mepolizumab reduces exacerbations in patients with severe eosinophilic asthma, irrespective of body weight/body mass index: meta-analysis of MENSA and MUSCA
por: Albers, Frank C., et al.
Publicado: (2019)

A Case of Acute Eosinophilic Myopericarditis Presenting with Cardiogenic Shock and Normal Peripheral Eosinophil Count
por: Sohn, Il Suk, et al.
Publicado: (2006)

Mepolizumab improves clinical outcomes in patients with severe asthma and comorbid conditions
por: Gibson, Peter G., et al.
Publicado: (2021)

Effect of inhaled corticosteroids on blood eosinophil count in steroid-naïve patients with COPD
por: Kreindler, James L, et al.
Publicado: (2016)

Management of the patient with eosinophilic asthma: a new era begins
por: de Groot, Jantina C., et al.
Publicado: (2015)

Determination of sputum eosinophil count and serum absolute eosinophil count in patients with bronchial asthma and its correlation with disease severity and response to treatment
por: Mangattu Parambil, Princia Banu, et al.
Publicado: (2023)

Blood eosinophil count, a marker of inhaled corticosteroid effectiveness in preventing COPD exacerbations in post-hoc RCT and observational studies: systematic review and meta-analysis
por: Harries, Timothy H., et al.
Publicado: (2020)

Eosinophil Development, Regulation of Eosinophil-Specific Genes, and Role of Eosinophils in the Pathogenesis of Asthma
por: Uhm, Tae Gi, et al.
Publicado: (2012)

Clinical profile of patients with adult-onset eosinophilic asthma
por: de Groot, Jantina C., et al.
Publicado: (2016)

Stopping versus continuing long-term mepolizumab treatment in severe eosinophilic asthma (COMET study)
por: Moore, Wendy C., et al.
Publicado: (2022)

Eosinophils as Drivers of Severe Eosinophilic Asthma: Endotypes or Plasticity?
por: Van Hulst, Glenn, et al.
Publicado: (2021)

Inhaled corticosteroid effects both eosinophilic and non-eosinophilic inflammation in asthmatic patients.
por: Basyigit, Ilknur, et al.
Publicado: (2004)

Efficacy and safety of mepolizumab in Korean patients with severe eosinophilic asthma from the DREAM and MENSA studies
por: Kim, Mi-Kyeong, et al.
Publicado: (2021)

Eosinophilic inflammation, coronavirus disease 2019, and asthma: Are inhaled corticosteroids the missing link?
por: Ramakrishnan, Sanjay, et al.
Publicado: (2021)

Omalizumab Restores Response to Corticosteroids in Patients with Eosinophilic Chronic Rhinosinusitis and Severe Asthma
por: Kobayashi, Yoshiki, et al.
Publicado: (2021)

Shared genetic architecture of blood eosinophil counts and asthma in UK Biobank
por: Li, Boyang, et al.
Publicado: (2023)

Eosinophil Progenitors in Patients With Non-Asthmatic Eosinophilic Bronchitis, Eosinophilic Asthma, and Normal Controls
por: Zhan, Chen, et al.
Publicado: (2022)

Severe Eosinophilic Asthma
por: Bakakos, Agamemnon, et al.
Publicado: (2019)

Eosinophils and childhood asthma
por: Choi, Bong Seok
Publicado: (2021)

Oral corticosteroid-sparing effects of reslizumab in the treatment of eosinophilic granulomatosis with polyangiitis
por: Kent, Brian D., et al.
Publicado: (2020)

The identification of eosinophilic gastroenteritis in prednisone-dependent eosinophilic bronchitis and asthma
por: Nair, Parameswaran, et al.
Publicado: (2011)

Similar activation of sputum granulocytes in eosinophilic and non-eosinophilic asthma
por: Hilvering, Bart, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_q5loa38povd0pqcc8grsieu0f3